Page last updated: 2024-08-17

levodopa and Cerebellar Ataxia

levodopa has been researched along with Cerebellar Ataxia in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19904 (26.67)18.7374
1990's2 (13.33)18.2507
2000's3 (20.00)29.6817
2010's4 (26.67)24.3611
2020's2 (13.33)2.80

Authors

AuthorsStudies
Daida, K; Hattori, N; Kamo, R; Nishioka, K; Shimada, T; Tsunemi, T1
Ikezawa, J; Shimazaki, R; Sugaya, K; Takahashi, K; Tobisawa, S1
Cheon, SM; Jeong, YJ; Kang, DY; Kim, JW1
Barliya, A; Flash, T; Franzén, E; Horak, FB; Inzelberg, R; Israeli-Korn, SD; Paquette, C1
Abele, M; Albanese, A; Barone, P; Berciano, J; Boesch, S; Bozi, M; Cardozo, A; Coelho, M; Colosimo, C; Daniels, C; Del Sorbo, F; Deuschl, G; Djaldetti, R; Dupont, E; Fowler, C; Galitzky, M; Gasser, T; Geser, F; Giladi, N; Gonzalez-Mandly, A; Gurevich, T; Kamm, C; Klockgether, T; Köllensperger, M; Mathias, CJ; Meco, G; Ndayisaba, JP; Nilsson, CF; Oertel, W; Ostergaard, K; Pellecchia, MT; Poewe, W; Quinn, N; Rascol, O; Sampaio, C; Schimke, N; Schrag, A; Seppi, K; Siebert, U; Tison, F; Tolosa, E; Wenning, GK; Widner, H; Yekhlef, F1
Franzén, E; Horak, FB; Jones, GM; Paquette, C1
Fukui, Y; Han, SY; Jeong, YG; Kawk, JH; Kim, CT; Lee, NS; Sawada, K1
Berry-Kravis, E; Hagerman, PJ; Hagerman, RJ; Hall, DA; Leehey, MA; Rice, CD1
Fujiki, N; Sasaki, H; Soma, H; Takei, A; Yabe, I; Yanagihara, T1
Morgan, MH1
Goetz, CG; Klawans, HL; Tanner, CM1
Mizuno, M; Shimizu, N1
Kawai, H; Mitsui, T; Miyata, M; Saito, S; Sakoda, S1
Albanese, A; Ben-Shlomo, Y; Fowler, CJ; Gilman, S; Kaufmann, H; Klockgether, T; Lang, AE; Lantos, PL; Litvan, I; Low, PA; Mathias, CJ; Oliver, E; Quinn, N; Robertson, D; Schatz, I; Wenning, GK1
Fukuma, N; Nihei, N1

Reviews

2 review(s) available for levodopa and Cerebellar Ataxia

ArticleYear
Ataxia--its causes, measurement, and management.
    International rehabilitation medicine, 1980, Volume: 2, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; Anticonvulsants; Antipsychotic Agents; Ataxia; Cerebellar Ataxia; Humans; Levodopa; Movement; Self-Help Devices

1980
Consensus statement on the diagnosis of multiple system atrophy.
    Journal of the neurological sciences, 1999, Feb-01, Volume: 163, Issue:1

    Topics: Autonomic Nervous System Diseases; Cerebellar Ataxia; Diagnosis, Differential; Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Urination Disorders

1999

Other Studies

13 other study(ies) available for levodopa and Cerebellar Ataxia

ArticleYear
Radiation-induced Brain Calcification Leads to L-dopa-resistant Parkinsonism and Cerebellar Ataxia.
    Internal medicine (Tokyo, Japan), 2022, Dec-15, Volume: 61, Issue:24

    Topics: Brain; Calcinosis; Cerebellar Ataxia; Corpus Striatum; Female; Humans; Levodopa; Neurodegenerative Diseases; Parkinsonian Disorders; Tomography, Emission-Computed, Single-Photon

2022
Dopa-responsive dystonia in spinocerebellar ataxia 6: A case report.
    Clinical neurology and neurosurgery, 2023, Volume: 229

    Topics: Aged; Cerebellar Ataxia; Dystonia; Female; Humans; Levodopa; Spinocerebellar Ataxias

2023
F-18 FP-CIT PET in Multiple System Atrophy of the Cerebellar Type: Additional Role in Treatment.
    Contrast media & molecular imaging, 2017, Volume: 2017

    Topics: Aged; Cerebellar Ataxia; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Positron-Emission Tomography; Tropanes

2017
Intersegmental coordination patterns are differently affected in Parkinson's disease and cerebellar ataxia.
    Journal of neurophysiology, 2019, 02-01, Volume: 121, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Basal Ganglia; Biomechanical Phenomena; Cerebellar Ataxia; Cerebellum; Female; Gait; Humans; Levodopa; Lower Extremity; Male; Middle Aged; Models, Neurological; Muscle, Skeletal; Parkinson Disease

2019
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
    Movement disorders : official journal of the Movement Disorder Society, 2010, Nov-15, Volume: 25, Issue:15

    Topics: Age of Onset; Antiparkinson Agents; Cerebellar Ataxia; Europe; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Registries; Shy-Drager Syndrome

2010
Walking in circles: navigation deficits from Parkinson's disease but not from cerebellar ataxia.
    Neuroscience, 2011, Sep-08, Volume: 190

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Biomechanical Phenomena; Cerebellar Ataxia; Female; Gait; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Psychomotor Performance; Walking

2011
The absence of phosphorylated tyrosine hydroxylase expression in the purkinje cells of the ataxic mutant pogo mouse.
    Anatomia, histologia, embryologia, 2006, Volume: 35, Issue:3

    Topics: Animals; Cerebellar Ataxia; Fluorescent Antibody Technique; Immunohistochemistry; Levodopa; Mice; Mice, Mutant Strains; Phosphorylation; Purkinje Cells; Tissue Distribution; Tyrosine; Tyrosine 3-Monooxygenase

2006
Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:10

    Topics: Adrenergic beta-Antagonists; Aged; Anxiety Disorders; Benzodiazepines; Carbidopa; Central Nervous System Agents; Cerebellar Ataxia; Cholinesterase Inhibitors; Dopamine Agonists; Female; Fragile X Syndrome; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neurologic Examination; Parkinsonian Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Tremor

2006
MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA.
    Journal of the neurological sciences, 2006, Nov-15, Volume: 249, Issue:2

    Topics: Adult; Aged; Antiparkinson Agents; Autonomic Nervous System; Cerebellar Ataxia; Death, Sudden; Diagnostic Imaging; Drug Resistance; Female; Follow-Up Studies; Humans; Japan; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Multiple System Atrophy; Parkinsonian Disorders; Phenotype; Retrospective Studies; Vocal Cord Paralysis

2006
The pharmacology of olivopontocerebellar atrophy.
    Advances in neurology, 1984, Volume: 41

    Topics: Adult; Amantadine; Atrophy; Baclofen; Brain Diseases; Carbidopa; Cerebellar Ataxia; Female; Humans; Levodopa; Male; Middle Aged; Olivary Nucleus; Pons; Propranolol; Syndrome

1984
Oculomotor characteristics of parkinsonism in comparison with those of cerebellar ataxia.
    Journal of neural transmission. Supplementum, 1983, Volume: 19

    Topics: Adult; Aged; Caloric Tests; Cerebellar Ataxia; Eye Movements; Female; Humans; Levodopa; Male; Meniere Disease; Middle Aged; Nystagmus, Pathologic; Ophthalmoplegia; Parkinson Disease; Postural Balance; Posture; Pursuit, Smooth; Saccades

1983
Hereditary parkinsonism with multiple system degeneration: beneficial effect of anticholinergics, but not of levodopa.
    Journal of the neurological sciences, 1994, Volume: 125, Issue:2

    Topics: Adult; Amantadine; Basal Ganglia; Carbidopa; Cerebellar Ataxia; Cholinergic Antagonists; Consanguinity; Drug Resistance; Female; Genes, Recessive; Globus Pallidus; Homovanillic Acid; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease; Pedigree; Trihexyphenidyl

1994
Studies on thyrotropin releasing hormone in cerebellar ataxia mutant mouse brain.
    Life sciences, 1986, May-05, Volume: 38, Issue:18

    Topics: alpha-Methyltyrosine; Animals; Brain; Brain Stem; Catecholamines; Cerebellar Ataxia; Cerebellum; Fusaric Acid; Hypothalamus; Levodopa; Methyltyrosines; Mice; Mice, Inbred C3H; Mice, Neurologic Mutants; Reserpine; Species Specificity; Thyrotropin-Releasing Hormone; Tyrosine 3-Monooxygenase

1986